Form 4 for NBIX NEUROCRINE BIOSCIENCES INC
Accepted 2023-12-27 00:00:00 ET · period of report 2023-12-22 · accession 0001209191-23-059768 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2023-12-27 | 2023-12-22 | NBIX | Cooke Julie | CHRO | M - OptEx | $73.04 | +24.0K | 31.3K | +330% | +$1.75M |
| DM | 2023-12-27 | 2023-12-22 | NBIX | Cooke Julie | CHRO | S - Sale+OE | $128.66 | -24.0K | 17.3K | -58% | -$3.09M |
| DM | 2023-12-27 | 2023-12-22 | NBIX | Cooke Julie | CHRO | M - OptEx | $73.04 | -24.0K | 8,129 | -75% | -$1.75M |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-12-22 | M | A | 10,000 | $61.82 | 27,263 | D | — | — | |
| 2 | Common | Common Stock | 2023-12-22 | S | D | 14,000 | $129.99 | 17,263 | D | — | — | (F2) Represents a weighted average sales price per share. These shares were sold in multiple transactions at prices ranging from $129.95 to $130.15. The Reporting Person has provided to the issuer, and will provide to any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range. |
| 3 | Common | Common Stock | 2023-12-22 | M | A | 14,000 | $81.05 | 31,263 | D | — | — | |
| 4 | Common | Common Stock | 2023-12-22 | S | D | 10,000 | $126.79 | 17,263 | D | — | — | (F3) Represents a weighted average sales price per share. These shares were sold in multiple transactions at prices ranging from $125.00 to $128.00. The Reporting Person has provided to the issuer, and will provide to any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range. (F4) 15,825 of the reported shares are held by the Cooke Family Trust of 2004 U/A 12/28/2004, of which the Reporting Person has voting and investment power. |
| 5 | Derivative | Non-Qualified Stock Option | 2023-12-22 | M | D | 10,000 | $61.82 | 23,532 | D | $61.82 · — to 2027-10-02 | 10,000 Common Stock | (F6) Option granted October 02, 2017 of which 1/4th of the shares underlying the option becomes vested and exercisable on October 02, 2018 and an additional 1/48th of the shares underlying the option becomes vested and excercisable each month thereafter. |
| 6 | Derivative | Non-Qualified Stock Option | 2023-12-22 | M | D | 14,000 | $81.05 | 8,129 | D | $81.05 · — to 2029-02-07 | 14,000 Common Stock | (F5) Option granted February 07, 2019 and vested monthly over four years. |